Ostensen M . Optimisation of antirheumatic drug treatment in pregnancy . Clin Pharmacokin1994; 27: 486–503 .
2.
Janssen NM , Genta M . The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation . Arch Intern Med2000; 160: 610–619 .
3.
Ostensen M , Ostensen H . Safety of nonsteroidal anti-inflammatory drugs in pregnant patients with rheumatic disease . J Rheumatol1996; 23: 1045–1049 .
4.
Takahashi Y , Roman C , Chemtob S et al. Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo . Am J Physiol Regulat Integrat Comp Physiol2000; 278: R1496–R1505 .
5.
Ostensen M . Z Rhematol2000; 59(Suppl 2): H70–H74 .
6.
Esplin MS , Branch WD . Immunosuppressive drugs and pregnancy . Obstet Gynecol Clin N Am1997; 24: 601–615 .
7.
Bemas BL , Hill JA . Effects of immunosuppressive drugs during pregnancy . Arthritis Rheum1995; 38: 1722–1732 .
8.
Rayburn WF . Glucocorticoid therapy for rheumatic diseases: maternal, fetal, and breast-feeding considerations . Am J Reprod Immunol1992; 28: 138–140 .
9.
Jarvis B , Faulds D . Etanercept: a review of its use in rheumatoid arthritis . Drugs1999; 57: 945–966 .
10.
O'Dell JR.TNF-a inhibition: the need for a tumor necrosis thermostat . Mayo Clin Proc2001; 76: 573–574 .
11.
Baghai M , Osmon DR , Wolk DM et al. Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept . Mayo Clin Proc2001; 76: 653–656 .
12.
Brent RL . Teratogen update: reproductive risks of Leflunomide (ARAVATM); a pyridime synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child . Teratology2001; 63: 106–112 .
13.
Parke A . Antimalarial drugs in pregnancy . Am J Med1988; 85(Suppl 4A): 30–33 .
14.
Buchanan NWM , Khamashta KB , Kerslake MS et al. A study of 100 high risk lupus pregnancies . Am J Reprod Immunol1992; 28: 192–194 .
15.
Hart CN , Naunton RF . The ototoxicity of chloroquine phosphate . Arch Otolaryngol Head Neck Surg1964; 80: 407–412 .
16.
Paufique IL , Magnard P . Retinal degeneration in two children following preventive antimalarial treatment of mother during pregnancy . Bull Soc Opthal Fr1969; 69: 466–467 .
17.
Harris EN . Syndrome of the Black Swan (Editorial) . Br J Rheumatol1987; 26: 324–326 .
18.
Wilson WA , Gharavi AE , Koike MD et al. International consensus statement on preliminary classification for definite antiphospholipid syndrome . Arthritis Rheum1999; 42: 1309–1311 .
19.
Cowchock FS , Reece EA , Balaban D et al. Repeated fetal losses, associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone to low dose heparin treatment . Am J Obstet Gynecol1992; 166: 1318–1327 .
20.
Branch DW , Silver RM , Blackwell JL et al. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience . Obstet Gynecol1992; 80: 614–620 .
21.
Kutteh WH , Ermel LD . A clinical trial for the treatment of antiphospholipid antibody— associated recurrent pregnancy loss with lower dose heparin and aspirin . Am J Reprod Immunol1996; 35: 402–407 .
22.
Rai R , Cohen H , Dover M , Regan L . Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospho-lipid antibodies) . Br Med J1997; 314: 253–257 .
23.
Clark AL , Branch DW , Silver RM et al. Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immuno-globulin therapy . Obstet Gynecol1999; 93: 437–441 .
24.
Branch DW , Peaceman AM , Druzin M et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy . Am J Obstet Gynecol2000; 182: 1227-1227 .
